FDA Person
FDAHaitao Li
View detailed information about Haitao Li, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 6 inspections of 6 companies, 2018–2024.
Inspections (6)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| October 4, 2024 | KREATIVE ACTIVES PRIVATE LIMITED | Not classified | #1253852 | |
| May 17, 2024 | Sun Pharmaceutical Industries Ltd | VAI | Drug Quality Assurance | #1240730 |
| May 8, 2024 | Cipla, Ltd. | VAI | Drug Quality Assurance | #1236690 |
| February 9, 2024 | Novartis d.o.o. | VAI | Generic Drug Evaluation | #1229017 |
| January 25, 2019 | American Regent, Inc. | OAI | New Drug Evaluation | #1078679 |
| October 26, 2018 | Alembic Pharmaceuticals Limited | OAI | Generic Drug Evaluation | #1069852 |
Documents (4)
- 483 · Cipla, Ltd. · May 6, 2024
- 483 · American Regent, Inc. · January 25, 2019
- 483 · Sun Pharmaceutical Industries Ltd · May 13, 2024
- 483 · Novartis d.o.o. · February 9, 2024
Person Information
Name
Haitao Li
Role
ISSUING OFFICER
ID: 62ce7565-d80f-4570-962a-8e6bfc88d0c1
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.